ADC Therapeutics SA Stock Issued During Period, Shares, Conversion of Convertible Securities
ADC Therapeutics SA (ADCT) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 2.39 million shares as of 2022-08-15, per its 10-K filed 2024-03-13.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2024-03-13
- 2022-08-15: Stock Issued During Period, Shares, Conversion of Convertible Securities 2.39M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2022-08-15 | 2.39M shares 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |